Medigate, the first dedicated medical device security and asset management platform, today announced it was named to the Constellation ShortList™ for Medical Device Security in Q3 2019. Medigate’s unique medical device security and asset management platform addresses both clinical Internet of Medical Things (IoMT) and general IoT devices, enabling accurate and comprehensive device discovery, contextual and behavioral anomaly detection, and clinical policy enforcement for healthcare organizations’ entire clinical networks.
Medigate provides three capabilities essential for effective IT security: visibility into all network connected devices, detection of potential threats and automated prevention of attacks. These capabilities are specifically designed for the healthcare industry, differentiating Medigate from other solutions.
“In recent years, we’ve seen an increase of cyberattacks in the healthcare sector due to vulnerabilities within medical device networks, creating exposure and even affecting the quality of patient care,” said Jonathan Langer, co-founder and CEO of Medigate. “Being named to the Constellation ShortList validates our efforts in helping healthcare organizations protect everything on their networks and overcome the security threats that the industry is facing today.”
“In our experience working on tens of thousands of vendor selections, we’ve learned that no two organizations have the same requirements. We cut through the clutter and marketing hype and present the top offerings in each of our coverage areas. These vendors have battle tested solutions that our analysts have vetted and approved,” said R “Ray” Wang, chairman and founder at Constellation Research.
Constellation Research advises leaders on leveraging disruptive technologies to achieve business model transformation. Products and services named to the Constellation ShortList meet the threshold criteria for this category as determined through client inquiries, partner conversations, customer references, vendor selection projects, market share and internal research. The portfolio is frequently updated every six months with the rapidly changing market conditions.
For more information, visit: https://www.medigate.io/.
Constellation Research does not endorse any solution or service named in its research.
Medigate is the industry’s first and leading dedicated medical device security and asset management platform, enabling providers to deliver secure, connected care. Medigate fuses the knowledge and understanding of medical workflow and device identity and protocols with the reality of today’s cybersecurity threats. With Medigate, hospital networks can safely operate all medical devices on their network, enabling deployment of existing and new devices to patients while ensuring privacy and safety.